Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Elgqvist, Jörgen ; Andersson, Håkan ; Haglund, Elin ; Jensen, Holger ; Kahu, Helena ; Lindegren, Sture ; Warnhammar, Elisabet ; Hultborn, Ragnar. / Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities. In: Cancer Biotherapy & Radiopharmaceuticals. 2009 ; Vol. 24, No. 4. pp. 509-13.

Bibtex

@article{f23f350f12594ca2b9cfc55b73b6d68d,
title = "Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities",
abstract = "The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.",
author = "J{\"o}rgen Elgqvist and H{\aa}kan Andersson and Elin Haglund and Holger Jensen and Helena Kahu and Sture Lindegren and Elisabet Warnhammar and Ragnar Hultborn",
year = "2009",
month = "8",
day = "1",
doi = "10.1089/cbr.2009.0618",
language = "English",
volume = "24",
pages = "509--13",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann/Liebert, Inc. Publishers",
number = "4",

}

RIS

TY - JOUR

T1 - Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities

AU - Elgqvist, Jörgen

AU - Andersson, Håkan

AU - Haglund, Elin

AU - Jensen, Holger

AU - Kahu, Helena

AU - Lindegren, Sture

AU - Warnhammar, Elisabet

AU - Hultborn, Ragnar

PY - 2009/8/1

Y1 - 2009/8/1

N2 - The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.

AB - The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.

U2 - 10.1089/cbr.2009.0618

DO - 10.1089/cbr.2009.0618

M3 - Journal article

VL - 24

SP - 509

EP - 513

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 4

ER -

ID: 32158868